Scarica l'app Stockscreener
73.51
1.96%
1.4218
Precedente Chiudi:
$72.09
Aprire:
$72.5
Volume 24 ore:
314.27K
Relative Volume:
0.35
Capitalizzazione di mercato:
$12.72B
Reddito:
$8.31B
Utile/perdita netta:
$379.00M
Rapporto P/E:
34.03
EPS:
2.16
Flusso di cassa netto:
$385.00M
1 W Prestazione:
+1.28%
1M Prestazione:
-0.41%
6M Prestazione:
-1.09%
1 anno Prestazione:
+26.25%
Intervallo 1D:
$72.12
$73.73
Intervallo di 1 settimana:
$71.34
$74.98
Portata 52W:
$57.48
$85.92
Solventum Corp Stock (SOLV) Company Profile
Nome
Solventum Corp
Settore
Industria
Telefono
651-733-1110
Indirizzo
C/O 3M COMPANY, ST. PAUL
Confronta SOLV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
73.53 | 12.46B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
481.59 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.42 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
289.36 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
86.53 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
244.06 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Aggiornamento | Argus | Hold → Buy |
| 2025-06-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | Piper Sandler | Neutral |
| 2024-09-26 | Iniziato | Wolfe Research | Peer Perform |
| 2024-09-05 | Iniziato | BTIG Research | Neutral |
| 2024-06-24 | Iniziato | Argus | Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2024-05-10 | Iniziato | BofA Securities | Neutral |
| 2024-04-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Iniziato | Wells Fargo | Equal Weight |
| 2024-04-02 | Iniziato | Edward Jones | Hold |
Mostra tutto
Solventum Corp Borsa (SOLV) Ultime notizie
Solventum Corporation (SOLV) Reports Q2 2025 Results; Mizuho and Wells Fargo Reiterate Their Ratings - ca.finance.yahoo.com
Solventum ups financial guidance as tariff risks fade - MSN
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks? - MSN
Will Strong Q2 Results and Raised Outlook Change Solventum's (SOLV) Narrative? - simplywall.st
Solventum raises annual profit forecast on strength in surgical equipment - MSN
Piper Sandler Boosts Solventum (NYSE:SOLV) Price Target to $94.00 - MarketBeat
Should Solventum's (SOLV) Earnings Upgrade and Revenue Growth Prompt Portfolio Reassessment by Investors? - simplywall.st
Solventum 2025 Q2 Earnings Net Income Rises 1.1% - AInvest
Stock Analysis | Solventum OutlookNavigating Mixed Signals Amid Weak Technicals - AInvest
Solventum Q2 FY25 slides reveal improved performance and increased full-year outlook - Investing.com Canada
Solventum Exceeds 2Q25 Expectations with $2.16B Revenue, Reduces Tariff Impact - Medical Device and Diagnostic industry
Goldman Sachs Adjusts Solventum Price Target to $73 From $71, Maintains Sell Rating - MarketScreener
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve - The Globe and Mail
Solventum Stock Gains On Q2 Earnings & Revenue Beat, Margins Improve - Barchart.com
Solventum raises 2025 EPS guidance to $5.80-$5.95 with sales growth outlook up to 3% as transformation gains momentum - MSN
Solventum Boosts Annual Profit Outlook on Surging Medical Device DemandNews and Statistics - IndexBox
Solventum stock price target raised to $94 by Piper Sandler on strong Q2 - Investing.com Nigeria
Solventum price target raised to $94 from $87 at Piper Sandler - TipRanks
Solventum rises after lifting annual profit forecast - TradingView
Solventum Raises EPS Guidance to $5.80-$5.95, Sales Growth Outlook Up to 3% Amid Transformation Gains - AInvest
Earnings call transcript: Solventum’s Q2 2025 earnings beat expectations - Investing.com
Earnings call transcript: Solventum’s Q2 2025 earnings beat expectations By Investing.com - Investing.com UK
Solventum: Q2 Earnings Snapshot - Connecticut Post
Morgan Stanley Upgrades Solventum (SOLV) on Growth Potential - MSN
Solventum Corp SEC 10-Q Report - TradingView
Solventum Q2 FY25 slides reveal improved performance and increased full-year outlook By Investing.com - Investing.com South Africa
Solventum 2025 Q2 Earnings Positive Earnings Growth with Raised Guidance - AInvest
Solventum (SOLV) Fiscal Q2 EPS Jumps 8% - AOL.com
Solventum Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Solventum (SOLV) Q2 2025 Earnings Call Transcript - Fortune
Solventum (SOLV) Reports Earnings Tomorrow: What To Expect - MSN
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Transcript : Solventum Corporation, Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Solventum shares surge as raised guidance tops expectations By Investing.com - Investing.com South Africa
Solventum shares surge as raised guidance tops expectations - Investing.com
Solventum reports Q2 adjusted EPS $1.69, consensus $1.45 - TipRanks
Solventum raises annual profit forecast on strength in surgical equipment By Reuters - Investing.com
Solventum Corporation Q2 Sales Increase - Nasdaq
Solventum beats The Street in Q2, raises full-year guidance - MassDevice
Solventum Q2 sales up 3.9% YoY, raises FY23 EPS outlook to $5.80-$5.95. - AInvest
Solventum’s (NYSE:SOLV) Q2: Beats On Revenue - Yahoo Finance
Earnings Flash (SOLV) Solventum Corporation Reports Q2 Revenue $2.16B, vs. FactSet Est of $2.12B - MarketScreener
Earnings Flash (SOLV) Solventum Corporation Posts Q2 Adjusted EPS $1.69 per Share, vs. FactSet Est of $1.45 - MarketScreener
Solventum Reports Second Quarter 2025 Financial Results - PR Newswire
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings? - MSN
Ahead of Solventum (SOLV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics - MSN
Solventum Corp Azioni (SOLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Solventum Corp Azioni (SOLV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| MAY KAREN J | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Mily Elizabeth | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,626 |
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):